FOI 7790 - Local Treatment Guidelines Non Small Cell Lung Cancer

Date: 24 March 2023 to 24 March 2026

  1. Does Medway NHS Foundation Trust have any local treatment guidelines/pathways/protocols/algorithms for the treatment of non-small cell lung cancer?
  2. Does Medway NHS Foundation Trust have protocols for the use of the following targeted drug therapies in the treatment of non-small cell lung cancer?
  3. If a local protocol for the use of Sotorasib (Lumykras) for the treatment of non-small cell lung cancer is available please could a copy be provided?
  4. Does Medway NHS Foundation Trust have any local pathways/protocols/guidelines for the use of molecular biomarker testing in diagnosis/treatment of non-small cell lung cancer?
  5. Is Medway NHS Foundation Trust part of a Cancer alliance or network, if so which ones?
  • Request ID:
    FOI 7790
  • Category:
    Clinical - Service Activity Data
  • Response:

    March 2023

    1. Does Medway NHS Foundation Trust have any local treatment guidelines/pathways/protocols/algorithms for the treatment of non-small cell lung cancer?  The Trust's non-small cell lung cancer patients are treated locally but the treatment decisions are made by the oncology team at Maidstone and Tunbridge Wells NHS Foundation Trust - Kent Oncology Centre, please contact them for their local guidelines.
    2. Does Medway NHS Foundation Trust have protocols for the use of the following targeted drug therapies in the treatment of non-small cell lung cancer?  Not applicable, please see above.
    3. If a local protocol for the use of Sotorasib (Lumykras) for the treatment of non-small cell lung cancer is available please could a copy be provided?  Not Applicable
    4. Does Medway NHS Foundation Trust have any local pathways/protocols/guidelines for the use of molecular biomarker testing in diagnosis/treatment of non-small cell lung cancer? No
    5. Is Medway NHS Foundation Trust part of a Cancer alliance or network, if so which ones? Yes - Kent and Medway Cancer Alliance